Skip to main content
. 2020 Apr 1;39:101166. doi: 10.1016/j.ctcp.2020.101166

Table 2.

Comparison of lung function, quality of life, and anxiety and depression between the two groups before and after intervention (M ± SD).


Measures
Intervention group (n = 36)
Control group (n = 36)
Pre Post 6 weeks ago After 6 weeks
Pulmonary Function Test
FEV1(L) 1.10 ± 0.08 1.44 ± 0.25*# 1.13 ± 0.14 1.26 ± 0.32
FVC(L) 1.79 ± 0.53 2.36 ± 0.49*# 1.77 ± 0.64 2.08 ± 0.37
FEV1/FVC% 60.48 ± 6.39 68.19 ± 6.05*# 60.44 ± 5.77 61.23 ± 6.43
TLCO % 60.3 ± 11.3 78.1 ± 12.3*# 60.7 ± 12.0 63.0 ± 13.4
Exercise Capacity Test
6MWT, m 162.7 ± 72.0 212.3 ± 82.5*# 155.7 ± 82.1 157.2 ± 71.7
ADL
FIM 109.2 ± 13 109.4 ± 11.1 109.3 ± 10.7 108.9 ± 10.1
QoL (SF-36)
Physical health 52.4 ± 6.2 71.6 ± 7.6*# 53.2 ± 7.7 54.1 ± 7.5
Body role function 61.2 ± 6.6 75.9 ± 7.9*# 61.3 ± 7.2 62.0 ± 7.3
Physical pain 63.5 ± 7.4 78.3 ± 7.8*# 63.5 ± 8.1 62.9 ± 7.9
General health 61.8 ± 7.7 74.2 ± 7.9*# 61.8 ± 8.4 61.4 ± 6.9
Energy 60.6 ± 6.9 75.6 ± 7.1*# 60.5 ± 7.1 61.2 ± 6.3
Social function 59.4 ± 7.2 69.8 ± 6.4*# 59.5 ± 7.0 58.9 ± 6.6
Emotional role function 61.4 ± 6.9 75.7 ± 7.0*# 61.4 ± 7.3 60.8 ± 7.3
Mental health 61.5 ± 6.5 73.7 ± 7.6*# 61.6 ± 7.2 62.1 ± 7.6
Anxiety and depression assessment
SAS score 56.3 ± 8.1 47.4 ± 6.3*# 55.8 ± 7.4 54.9 ± 7.3
SDS score 56.4 ± 7.9 54.5 ± 5.9 55.9 ± 7.3 55.8 ± 7.1

* Compared with the same group after intervention, P < 0.05.

#Compared with the control group after intervention, P < 0.05.

FVC: forced vital capacity; FEV1: forced expiratory volume at 1 s; DLCO: diffusing lung capacity for carbon monoxide; 6MWT: 6-Minute Walk Test; FIM: Functional Independence Measure.